Author

David W. Morgens

Primary ORCID profile (0000-0002-5005-0669 · 9 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

David W. MorgensiD9 papers · Stanford Medicine

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

Christopher P. Walczak· 1 shared Dara E. Leto· 1 shared Joshua E. Elias· 1 shared Lichao Zhang· 1 shared Michael C. Bassik· 1 shared Ron R. Kopito· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Christopher P. Walczak

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Parallel genome-wide CRISPR analysis identifies a role for heterotypic ubiquitin chains in ER-associated degradation

Dara E. Leto, David W. Morgens, Lichao Zhang, Christopher P. Walczak, Joshua E. Elias, Michael C. Bassik, Ron R. Kopito

The paper uses CRISPR screening to identify cytosolic ubiquitin conjugating machinery involved in ERAD by analyzing substrate-specific ubiquitin chain conjugation.

bioRxiv · Jun 17, 2018 · PreprintCell Biology